Literature DB >> 25593533

Anticoagulation with bivalirudin during deep hypothermic circulatory arrest in a patient with heparin-induced thrombocytopenia.

Agamemnon Pericleous, Mostafa Sadek, Mary Fitzmaurice, Constance Caldwell, Kris Natividad, Konstadinos A Plestis.   

Abstract

Heparin-induced thrombocytopenia is a well-recognized complication of anticoagulation with heparin. We present the case of a patient with recent heparin-induced thrombocytopenia who subsequently needed surgery on an emergency basis for acute type A aortic dissection. This article reports the successful use of bivalirudin, a direct thrombin inhibitor, as an alternative to heparin throughout cardiopulmonary bypass and deep hypothermic circulatory arrest. We contend that bivalirudin is a safe alternative to heparin when performing surgery for aortic dissection and should be considered as an option for use in patients who present with heparin-induced thrombocytopenia.

Entities:  

Keywords:  Anticoagulants/adverse effects; aortic dissection; bivalirudin; blood coagulation; blood loss, surgical; cardiopulmonary bypass; circulatory arrest, deep hypothermia induced; hemofiltration; heparin/adverse effects; hirudins; thrombocytopenia/chemically induced/prevention & control

Mesh:

Substances:

Year:  2014        PMID: 25593533      PMCID: PMC4251340          DOI: 10.14503/THIJ-13-3631

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  13 in total

1.  An assessment of different filter systems for extracorporeal elimination of bivalirudin: an in vitro study.

Authors:  Andreas Koster; Derek Chew; Marcus Gründel; Harald Hausmann; Onnen Grauhan; Herman Kuppe; Bruce D Spiess
Journal:  Anesth Analg       Date:  2003-05       Impact factor: 5.108

2.  Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.

Authors:  George Gordon; Hassan Rastegar; Roman Schumann; Judith Deiss-Shrem; William Denman
Journal:  J Cardiothorac Vasc Anesth       Date:  2003-10       Impact factor: 2.628

3.  Direct thrombin inhibitors.

Authors:  Marcello Di Nisio; Saskia Middeldorp; Harry R Büller
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

4.  Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.

Authors:  Andreas Koster; Cornelius M Dyke; Gabriel Aldea; Nicholas G Smedira; Harry L McCarthy; Solomon Aronson; Roland Hetzer; Edwin Avery; Bruce Spiess; A Michael Lincoff
Journal:  Ann Thorac Surg       Date:  2007-02       Impact factor: 4.330

5.  Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition.

Authors:  J T Walls; J J Curtis; D Silver; T M Boley; R A Schmaltz; W Nawarawong
Journal:  Ann Thorac Surg       Date:  1992-05       Impact factor: 4.330

6.  Fulminate heparin-induced thrombocytopenia and surgery with deep hypothermic circulatory arrest using bivalirudin.

Authors:  Andreas Koster; Mohammad Amin-Parsa; Michael Kaufmann; Ties Meyer-Jark; Marcus Rudloff; Juergen Diekmann; Wolf-Martin Georg; Michael Liebke; Uwe Schirmer; Jan F Gummert
Journal:  Ann Thorac Surg       Date:  2013-03       Impact factor: 4.330

7.  Deep hypothermic circulatory arrest and bivalirudin use in a patient with heparin-induced thrombocytopenia and antiphospholipid syndrome.

Authors:  Kay B Leissner; Ara Ketchedjian; Richard Crowley; Rafael Ortega; Jan F Hesselvik; Richard J Shemin
Journal:  J Card Surg       Date:  2007 Jan-Feb       Impact factor: 1.620

8.  Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass.

Authors:  R L Singer; J D Mannion; T L Bauer; F R Armenti; R N Edie
Journal:  Chest       Date:  1993-11       Impact factor: 9.410

Review 9.  The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia.

Authors:  Andreas Greinacher
Journal:  Semin Thromb Hemost       Date:  2004-06       Impact factor: 4.180

10.  Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender.

Authors:  Richard Robson; Harvey White; Philip Aylward; Christopher Frampton
Journal:  Clin Pharmacol Ther       Date:  2002-06       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.